Financing advances development of Prota’s peanut allergy remission therapy in preparation for a Phase 3 clinical trial Prota Therapeutics Pty Ltd…
Browsing: Medical
Following the first official announcement at the beginning of December last year, Hyris completed the transfer of its shares into…
Affecting Drug Development Schedules and Financial Plans Avance Clinical, the leading Australian and North American CRO for biotechs announced today…
Spiden, a pioneer in non-invasive biomarker monitoring technology, is thrilled to announce a significant scientific milestone, key additions to its…
Newly-launched database offers easier access to diverse tumor models and unveils the path to pharmaceutical breakthroughs ChemPartner, a global leader…
German research institute BioMed X and Ono Pharmaceutical, a Japanese pharmaceutical company, started a new joint research project on cancer…
The Company’s ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to…
Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced that it…
Vesica AI, a promising medical startup company, has been selected as the winner of the inaugural Olympus Asia Pacific Innovation…
Report Shows Visa Certifications Hitting a New High in 2023 But a Decline is Likely With U.S. Immigration Limits In…